Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Ceribell (Nasdaq: CBLL) announced that Jane Chao, Ph.D., CEO and co‑founder will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ceribell (Nasdaq: CBLL) announced that Jane Chao, Ph.D., CEO and co‑founder will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 9:00 am PST / 12:00 pm EST.
A live and archived webcast of the presentation will be available in the Investor Relations section of Ceribell's website at https://investors.ceribell.com/.
Details
News Market Reaction – CBLL
On Dec 31, the first trading day after this news, CBLL closed 1.01% above the previous close.
Data tracked by StockTitan Argus for the Dec 31 session.
Key Figures
- Conference edition
- 44th
- 44th Annual J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Scheduled J.P. Morgan Healthcare Conference presentation
- Presentation time PST
- 9:00 am PST
- Timing of J.P. Morgan conference presentation
- Presentation time EST
- 12:00 pm EST
- Timing of J.P. Morgan conference presentation
- Shelf registration size
- $300,000,000
- Universal shelf on Form S-3 filed Nov 4, 2025
- Q3 2025 revenue
- $22.6M
- Third quarter 2025 financial results
- Q3 2025 net loss
- $13.5M
- Third quarter 2025 financial results
- FY25 revenue guidance
- $87M–$89M
- Raised full-year 2025 revenue guidance
Historical Context
-
FDA 510(k) clearance for delirium monitoring solution extending Ceribell System.
-
FDA 510(k) clearance for Clarity algorithm across neonatal to adult seizures.
-
Announcement of presentation at Piper Sandler 37th Annual Healthcare Conference.
-
CFO fireside chat at Canaccord Genuity MedTech and Digital Health forum.
-
Q3 2025 results with 31% revenue growth and raised full-year guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Monday, January 12, 2026, at 9:00 am Pacific Standard Time / 12:00 pm Eastern Standard Time.
Event: 44th Annual J.P. Morgan Healthcare Conference
Date: Monday, January 12, 2026
Time: 9:00 am PST / 12:00 pm EST
A live and archived webcast of the presentation will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.
About CeriBell, Inc.
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. Ceribell has developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared for use in detecting seizure and delirium in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California. For more information, please visit www.ceribell.com or follow the company on LinkedIn.
Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com
Media Contact
Brian Price
Press@ceribell.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.